November 16, 2018
3:30 – 5pm
After closing a $35 million Series B, ViewPoint Therapeutics will be moving to their own lab space in South San Francisco. They were one of the very first companies to move into MBC BioLabs San Francisco, and they have grown from two to nine full time employees. Please join us as we congratulate their success and wish them well!